Noradrenaline reuptake inhibitors and schizophrenia

Schizophrenia is a chronic illness characterised by a range of symptoms including positive and negative symptoms. Examples of positive symptoms include hallucinations, delusions, and...

Is technology helping make medicine use in Australia safer?

After chairing the Medication Safety and Efficiency Conference, Deborah Hawthorne reflects on whether digital health is making care safer.

Are antibiotics courses for common infections too long?

In the fight against antibiotic resistance, shorter courses of antibiotics are now recommended for patients with common infections, but how short is long enough? The...

Antidepressants and benzodiazepines for major depression

This evidence summary presents the best available evidence regarding the efficacy and safety of a combination of antidepressants and benzodiazepines for adults with major...

Ocular changes

A patient inquiry about ocular changes may provide pharmacists with an opportunity to screen or refer patients to an optometrist.

What you missed at PSA22 – Day 2

PSA22 continued on Saturday with a wide-ranging line-up of award presentations, therapeutic updates and industry engagement opportunities.